Compare COYA & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COYA | SRBK |
|---|---|---|
| Founded | 2020 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 125.0M |
| IPO Year | 2022 | N/A |
| Metric | COYA | SRBK |
|---|---|---|
| Price | $5.97 | $16.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | ★ 192.0K | 30.8K |
| Earning Date | 11-12-2025 | 01-30-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | N/A | ★ 374.69 |
| EPS | N/A | ★ 0.54 |
| Revenue | $3,987,706.00 | ★ $31,130,000.00 |
| Revenue This Year | $88.66 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $31.40 |
| Revenue Growth | N/A | ★ 0.85 |
| 52 Week Low | $4.65 | $11.36 |
| 52 Week High | $8.29 | $17.08 |
| Indicator | COYA | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 79.61 |
| Support Level | $6.00 | $15.57 |
| Resistance Level | $6.44 | $16.32 |
| Average True Range (ATR) | 0.29 | 0.42 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 0.70 | 89.83 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.